Shujing Xu
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, 44 West Culture Road
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Bridging the Gap between In Vitro and Intracellular: Systematic Analysis and Screening Optimization of Inconsistencies between Target Activity and Cellular-Level Activity.
Journal: Journal of medicinal chemistry
Published: May 15, 2026
Correction to "Phenotypic Screening: A Cornerstone Engine for Discovering Original Anti-Infective Drugs".
Journal: Journal of medicinal chemistry
Published: February 12, 2026
Phenotypic Screening: A Cornerstone Engine for Discovering Original Anti-Infective Drugs.
Journal: Journal of medicinal chemistry
Published: December 25, 2025
Anti-infective Drug Discovery: Harnessing Multimechanistic Molecules and Emergent Properties to Defeat Pathogenic Complexity.
Journal: Journal of medicinal chemistry
Published: September 11, 2025
Urate transporters: Structural mechanisms and therapeutic opportunities in drug development.
Journal: Acta pharmaceutica Sinica. B
Published: August 20, 2025
Alterations in the fat globule membrane proteome of cow, yak, buffalo, and camel milk in response to homogenization and heat treatment.
Journal: Journal of dairy science
Published: August 12, 2025
Antiviral strategies based on targeted protein degradation: An overview of the literature and future outlook.
Journal: European journal of medicinal chemistry
Published: July 03, 2025
Protein degradation-based anti-infective drug research.
Journal: Acta pharmaceutica Sinica. B
Published: June 18, 2025
Targeting the coronavirus membrane protein: A promising novel therapeutic strategy.
Journal: Acta pharmaceutica Sinica. B
Published: April 15, 2025
Antiviral drug discovery and development: challenges and future directions.
Journal: Signal transduction and targeted therapy
Published: September 27, 2024
Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimization.
Journal: Nature communications
Published: July 31, 2024
Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein.
Journal: Acta pharmaceutica Sinica. B
Published: June 03, 2024
Last Updated: 09/26/2026